Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression

Hazwani Mohd Yusof ¹ , Sharaniza Ab-Rahim ¹, Wan Zurinah Wan Ngah ², Sheila Nathan ³, A Rahman A Jamal ⁴, Musalmah Mazlan ¹ *

Cited by CrossRef: 5

1- Wang X, Guan X, Tong Y, Liang Y, Huang Z, Wen M, Luo J, Chen H, Yang S, She Z, Wei Z, Zhou Y, Qi Y, Zhu P, Nong Y, Zhang Q. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer. BMC Cancer. 2024;24(1) [Crossref]

2- Mio Asni N, Surya R, Mohmad Misnan N, Lim S, Ismail N, Sarbini S, Kamal N. Metabolomics insights of conventional and organic tempe during in vitro digestion and their antioxidant properties and cytotoxicity in HCT-116 cells. Food Research International. 2024;195:114951 [Crossref]

3- Naes S, Ab‑Rahim S, Mazlan M, Amir Hashim N, Abdul Rahman A. Increased ENT2 expression and its association with altered purine metabolism in cell lines derived from different stages of colorectal cancer. Exp Ther Med. 2023;25(5) [Crossref]

4- Sugishita T, Tokunaga M, Kami K, Terai K, Yamamoto H, Shinohara H, Kinugasa Y. Determination of the Minimum Sample Amount for Capillary Electrophoresis-Fourier Transform Mass Spectrometry (CE-FTMS)-Based Metabolomics of Colorectal Cancer Biopsies. Biomedicines. 2023;11(6):1706 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons